Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SIRS-Lab Gmbh (SIRS-Lab) has appointed Edward Currie as executive vice-president, corporate development of the company. In this newly created role, Edward will drive partnering, licensing, companion diagnostics, and corporate business development activities at SIRS-Lab. Edward, a physician specialized in clinical microbiology and infectious disease, brings 20 years of diagnostic and pharmaceutical industry experience at Eli Lilly, F. Hoffmann-La Roche, IBM.
Subscribe to our email newsletter
Most recently, Edward served as chief operating officer of Kuros BioSurgery. At Roche, as global head of disease management, Edward created the company’s first integrated Pharma-Diagnostic approach for targeted treatment and personalized medicine.
On his decision to join SIRS-Lab, Edward commented “I am very excited to be joining SIRS-Lab, a highly innovative company that I believe can make a real difference to the outcomes of patients with sepsis and life-threatening infections.”
Stefan Russwurm, chief executive officer of SIRS-Lab, stated: “We are delighted to welcome Dr. Currie here at SIRS-Lab. His highly regarded wealth of experience and an impressive track-record in the medical and diagnostic area, especially in the field of personalized medicine, will benefit us greatly in expanding our strategic partnerships.”